2023
DOI: 10.1007/s11259-023-10211-0
|View full text |Cite
|
Sign up to set email alerts
|

Antiviral mechanisms of sorafenib against foot-and-mouth disease virus via c-RAF and AKT/PI3K pathways

Sirin Theerawatanasirikul,
Varanya Lueangaramkul,
Ploypailin Semkum
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 47 publications
0
3
0
Order By: Relevance
“…The SOR presence likewise resulted in a reduction in the amplitude of I K(IR) , as observed in neonatal rat ventricular myocytes. This inhibition of ionic currents during SOR exposure may constitute an unintended yet crucial mechanism, contributing to alterations in QTc intervals or possibly influencing antiviral effects [9,19,[82][83][84]. These findings could offer insights into the occurrence of patients exhibiting QTc prolongation and, in some cases, experiencing subsequent fatal arrhythmias following treatment with SOR [10,85].…”
Section: Sm-102mentioning
confidence: 99%
See 1 more Smart Citation
“…The SOR presence likewise resulted in a reduction in the amplitude of I K(IR) , as observed in neonatal rat ventricular myocytes. This inhibition of ionic currents during SOR exposure may constitute an unintended yet crucial mechanism, contributing to alterations in QTc intervals or possibly influencing antiviral effects [9,19,[82][83][84]. These findings could offer insights into the occurrence of patients exhibiting QTc prolongation and, in some cases, experiencing subsequent fatal arrhythmias following treatment with SOR [10,85].…”
Section: Sm-102mentioning
confidence: 99%
“…Strategies for dose escalation have been contemplated for their clinical use, given that many malignancies are believed to be instigated by aberrant tyrosine kinase activity [81]. Tyrosine kinase inhibitors, such as sunitinib and SOtR, have recently been noticed to exert antiviral action [82][83][84]. A previous report has demonstrated the ability of SOR to suppress the amplitude of both the slowly activating delayed-rectifier K + current (I K(S) ) and I K(erg) identified in H9c2 cardiomyocytes [19,22].…”
Section: Sm-102mentioning
confidence: 99%
“…Sorafenib, a c-RAF and multi-kinase inhibitor, is approved for treating liver cancer [ 137 ]. Drug repurposing of sorafenib has been shown to inhibit viral replication in a wide range of viruses, and recent studies have found that sorafenib targets the FMDV 3D pol active site, inhibiting polymerase activity and modulating the c-RAF and AKT/PI3K pathways to inhibit FMDV replication [ 138 ].…”
Section: Drugs Acting On 3d Polmentioning
confidence: 99%